Alternative LDL cholesterol lowering strategy vs. high-intensity statin strategy: An individual patient data meta-analysis from the randomized RACING and LODESTAR trials
Event:
ESC Congress 2024
Topic:
Lipid-Lowering Agents
Session:
Smaller trials, trial updates, and other studies on lipid therapy
Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial